CURRICULUM, INSTRUCTION, AND PEDAGOGY article
Front. Public Health
Sec. Public Health Education and Promotion
Volume 12 - 2024 | doi: 10.3389/fpubh.2024.1493331
This article is part of the Research TopicVaccine Education and PromotionView all 31 articles
Community-Engaged Curriculum Development Using Racial Justice and Biomedical Lenses to Address COVID-19 Vaccine Hesitancy in Black Individuals with Rheumatologic Conditions
Provisionally accepted- 1Division of Rheumatology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United States
- 2Division of Rheumatology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States
- 3Governors State University College of Health and Human Services, University Park, IL, United States
- 4Rheumatology Program, Boston Children’s Hospital, Boston, MA, United States
- 5Vital CxNs, Boston, MA, United States
- 6Department of Rheumatology, Boston Medical Center, Boston, MA, United States
- 7Office of Community Engagement and Cancer Health Equity, Comprehensive Cancer Center, University of Chicago, Chicago, IL, United States
- 8Division of Neurology, Brigham and Women’s Hospital, Boston, MA, United States
- 9Lupus Society of Illinois, Chicago, IL, United States
- 10Alliance Chicago, Chicago, IL, United States
- 11Department of Internal Medicine and Dermatology, Brigham and Women's Hospital, Boston, MA, United States
- 12True Alliance Center, Inc, Boston, MA, United States
- 13Action for Bridgeport Community Development, Inc. (A.B.C.D., Inc.), Bridgeport, CT, United States
- 14Mattapan Community Development Corp; Women of Courage, Boston, MA, United States
- 15Division of General Internal Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United States
- 16The Orthopedic and Arthritis Center for Outcomes Research, Department of Orthopedics, Brigham and Women’s Hospital, Boston, MA, United States
- 17Harvard Medical School, Boston, Massachusetts, United States
- 18Division of Biostatistics, Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United States
- 19Mission Hill Health Movement Inc, Roxbury, MA, United States
- 20The Labalaba Foundation for Lupus Advocacy and Awareness, South Weymouth, MA, United States
- 21Boston Public Health Commission, Boston, Massachusetts, United States
- 22Division of Global Health Equity, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States
- 23Division of Rheumatology, Department of Medicine, Emory School of Medicine, Atlanta, GA, United States
- 24National Health Council, Department of Health Equity, Washington, D.C., United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Despite the efficacy of the COVID-19 vaccine in reducing mortality and illness severity, racial inequities in vaccination uptake persist. Among individuals with rheumatologic conditions who are often immunocompromised, the impact of disparities in preventive care threatens to widen existing inequities in adverse outcomes related to COVID-19 infection. There exists an urgent need to develop interventions that reduce COVID-19 vaccine hesitancy and promote vaccine uptake. We leveraged long-standing community-academic partnerships in two cities to develop a curriculum that will be part of an intervention to decrease COVID-19 vaccine hesitancy within Black communities. We describe the collaborative efforts that resulted in the creation of two interactive virtual curricula with similar core content but different theoretical lenses. One lens uses a racial justice approach to acknowledge the effects of historical and current structural racism on vaccine hesitancy, the other utilizes a traditional biomedical lens. In a future trial, we will compare the efficacy of these curricula to empower Black individuals identified as Popular Opinion Leaders (POLs), or trusted community members with large social networks, to disseminate health information to promote COVID-19 vaccine uptake. Strategies to reduce racial inequities in COVID-19 vaccine uptake must begin with accurately identifying and empathetically acknowledging the root causes of vaccine hesitancy, as well as addressing nuanced concerns that drive vaccine avoidance amongst Black individuals. Community engagement and collaboration are central in creating interventions to develop and test culturally relevant strategies, as observed with our curricula, that bridge scientific efforts with community concerns and practices.
Keywords: community academic partnerships, COVID-19, African American/Black, Community health promotion, health equity, Rheumatic and Autoimmune Disease, Vaccine hesitancy
Received: 09 Sep 2024; Accepted: 24 Dec 2024.
Copyright: © 2024 Osaghae, Sirek, Roberson, Chandler, Childs, Crespo-Bosque, Curry, Dhand, Dollear, Eggleston, Ezeh, Fleurissaint, Garrett, Granville, Jean- Jacques, Losina, Milaeger, Muhammad, Nelson, Nosamiefan, Ojikutu, Pillai, Jacques Toussaint, Son, Valle, Williams, York, Mancera-Cuevas, Feldman and Ramsey-Goldman. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Eseosa Osaghae, Division of Rheumatology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.